Intelligent Investor

QRxPharma Limited (ASX: QRX) - Share Price and Research

DELISTED - Current share price for QRX : $0.028

QRX General Information +

ASX Code QRX
Website N/A
Industry/Sector Pharmaceuticals
Market Cap ($M) n/a
QRX Share Price $0.028
Day High $0.029
Day Low $0.017
Last Close $0.028
QRX Share Price Movement - ( No change )
Prices as at 16:35, 24 May 2018
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

QRX Related Research

QRxPharma Limited (QRX) Upcoming Dividends & Yields

There are no dividends for QRxPharma Limited (QRX). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

QRxPharma Limited (QRX) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Removal from Official List 23 May 2018 8:33AM $0.028 $0.028 $0.028 fallen by 0%
Appendix 4C - Quarter Ended 31 March 2018 20 Apr 2018 10:18AM $0.028 $0.028 $0.028 fallen by 0%
Initial Director's Interest Notice 27 Mar 2018 9:45AM $0.028 $0.028 $0.028 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from QRxPharma Limited (QRX) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

QRX Directors

Name Position Start Date
Mr John P Rainbow Non-Executive Director 11 Oct 2016
Mr Anthony Jefferies Non-Executive Director 23 Mar 2018
Mr Timothy P Heesh Non-Executive Director 11 Oct 2016

QRxPharma Limited (QRX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
28 May 2015 HANCOX, Bruce Sell Indirect Shares 740,000 $0.017 $12,580.000
13 Dec 2013 CAMPBELL, Robert (Peter) Issued Indirect Shares 18,750 $0.600 $11,250.000
21 Nov 2012 QUINN, Michael Sell Indirect Shares 7,982,775 $0.765 $6,106,822.875

See all changes in directors' interest & trades for QRxPharma Limited (QRX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

QRX Management

Name Position
Cameron Jones Company Secretary

QRX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (QRX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
19,746,950 (12.03%) Allan Gray Australia Pty Ltd
15,653,120 (9.53%) Walker Group Holdings Pty Limited

FAQs about QRxPharma Limited (QRX)

QRxPharma Limited's (QRX) current share price is $0.03. This constitutes a price movement of 0% when compared to the share price 7 days ago and is n/a below QRX's 12-month high of n/a per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.03, QRxPharma Limited's (QRX) current share price of $0.03 constitutes a movement of or 0%. QRxPharma Limited's (QRX) share price movement is 0% when compared to 7 days ago and is n/a below QRX's 52-week high of n/a.

QRxPharma Limited (QRX) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for QRX is a ratio that tells you the percentage of QRxPharma Limited's (QRX) share price that it pays out in dividends each year.

QRxPharma Limited (QRX) will release its next Annual Report on n/a. QRxPharma Limited's (QRX) last annual report was released on 28 Sep 2017. Click here to view QRxPharma Limited's (QRX) last annual report.

QRxPharma Limited (QRX) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.